Embree Financial Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
31,407
+649
+2% +$59.2K 0.29% 60
2026
Q1
$3.16M Buy
30,758
+99
+0.3% +$11.2K 0.37% 56
2025
Q4
$3.84M Buy
30,659
+5,528
+22% +$704K 0.47% 48
2025
Q3
$3.37M Sell
25,131
-2,495
-9% -$328K 0.45% 50
2025
Q2
$3.76M Sell
27,626
-1,146
-4% -$151K 0.57% 37
2025
Q1
$3.82M Buy
28,772
+1,705
+6% +$217K 0.64% 33
2024
Q4
$3.06M Sell
27,067
-1,190
-4% -$138K 0.52% 37
2024
Q3
$3.22M Buy
28,257
+3,220
+13% +$353K 0.57% 38
2024
Q2
$2.6M Sell
25,037
-1,991
-7% -$211K 0.5% 45
2024
Q1
$3.07M Sell
27,028
-1,274
-5% -$146K 0.6% 41
2023
Q4
$3.12M Buy
+28,302
New +$2.83M 0.66% 36

Other funds holding ABT

Embree Financial Group's ABT Position: Q2 2026 in Review

Embree Financial Group increased its Abbott (ABT) stake by 2.1% in Q2 2026, buying an estimated $59.2K and bringing the position to 31,407 shares worth $2.85M. The position accounts for 0.29% of the portfolio, ranked #60.

Embree Financial Group first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.84M in Q4 2025. 1,574 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Embree Financial Group held 31,407 shares of Abbott worth $2.85M as of Q2 2026.
  • Embree Financial Group bought 649 Abbott shares in Q2 2026, an estimated $59.2K.
  • Abbott made up 0.29% of Embree Financial Group's portfolio in Q2 2026, its #60 holding.
  • Embree Financial Group first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Embree Financial Group's Abbott position peaked at $3.84M in Q4 2025.
  • 1,574 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.